title: Direct inhibition of choline kinase by a near-infrared fluorescent carbocyanine.
abstract: Choline kinase alpha (ChoK) expression is increasingly being recognized as an important indicator of breast cancer prognosis; however, previous efforts to noninvasively measure ChoK status have been complicated by the spectral limitations of in vivo magnetic resonance spectroscopy (MRS) and the complex network of enzymes involved in choline metabolism. The most effective ChoK inhibitors are symmetric and contain quaternary ammonium groups within heterocyclic head groups connected by an aliphatic spacer. Characterization of these bis-pyridinium and bis-quinolinium compounds has led to phase I clinical trials to assess small-molecule inhibitors of ChoK for solid tumor treatment. We report the development of a novel carbocyanine dye, JAS239, whose bis-indolium structure conforms to the parameters established for ChoK specificity and whose spacer length confers fluorescence in the near-infrared (NIR) window. Fluorimetry and confocal microscopy were used to demonstrate that JAS239 rapidly enters breast cancer cells independent of the choline transporters, with accumulation in the cytosolic space where ChoK is active. Radio-tracing and (1)H MRS techniques were used to determine that JAS239 binds and competitively inhibits ChoK intracellularly, preventing choline phosphorylation while inducing cell death in breast cancer cell lines with similar efficacy to known ChoK inhibitors. Fluorescent molecules that report on ChoK status have potential use as companion diagnostics for noninvasive breast tumor staging, because NIR fluorescence allows for detection of real-time probe accumulation in vivo. Furthermore, their ability as novel ChoK inhibitors may prove effective against aggressive, therapy-resistant tumors.
authors.affiliation: Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania.
authors.forename: Sean P
authors.initials: SP
authors.lastname: Arlauckas
authors.affiliation: Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania.
authors.forename: Anatoliy V
authors.initials: AV
authors.lastname: Popov
authors.affiliation: Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania. delikatn@mail.med.upenn.edu.
authors.forename: Edward J
authors.initials: EJ
authors.lastname: Delikatny
mesh_terms: D000255:Adenosine Triphosphate / Q000737:chemistry; D001943:Breast Neoplasms / Q000188:drug therapy; D002232:Carbocyanines / Q000737:chemistry*; D045744:Cell Line, Tumor; D002470:Cell Survival; D002797:Choline Kinase / Q000037:antagonists & inhibitors*; D003600:Cytosol / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000737:chemistry*; D005260:Female; D005456:Fluorescent Dyes / Q000737:chemistry*; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D018613:Microscopy, Confocal; D011379:Prognosis; D019265:Spectroscopy, Near-Infrared
chemical_list: D002232:Carbocyanines; D004791:Enzyme Inhibitors; D005456:Fluorescent Dyes; D000255:Adenosine Triphosphate; D002797:Choline Kinase